Light Sciences Oncology Obtains $40,100,000 Series C Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9e984961-e3d2-4d09-b77d-43261546d71e&Preview=1 -
Date
7/17/2008 -
Company Name
Light Sciences Oncology -
Mailing Address
15405 SE 37th Street Bellevue, WA 98006 -
Company Description
Light Sciences Oncology is developing Light Infusion Therapy (Litx™), an innovative light-activated treatment for solid tumors. LSO is currently developing Litx™ for the treatment of patients with cancers such as hepatoma, metastatic colorectal cancer and glioma, for which the current therapeutic alternatives are of limited efficacy. -
Website
http://www.lsoncology.com -
Transaction Type
Venture Equity -
Transaction Amount
$40,100,000 -
Transaction Round
Series C -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
Share
